Skip to main content
. 2020 Sep 1;10(9):2993–3036.

Figure 5.

Figure 5

Mechanism of miRNAs as emerging epigenetic targets for HCC therapy. miRNAs (microRNAs), CLK3 (CDC Like Kinase 3), SOCS3 (suppressor of cytokine signaling 3), EMT (epithelial-mesenchymal transition), GOLPH3 (Golgi phosphoprotein-3), TMPRSS4 (transmembrane protease serines 4), SPP1 (secreted phosphoprotein 1), FOXQ1 (Forkhead box Q1), IGF-1 (insulin-like growth factor-1).